The Munich-based e-health startup Temedica has received a seven-figure sum from a recently closed financing round. The capital is provided by a consortium of private investors, including Bernd Wendeln and Herbert Henzler. The financing round was prepared by BayStartUP. Business angels and MicroNova AG had already invested in the company in an earlier round.
Temedica develops digital solutions to support medical therapies and preventative healthcare. The company plans to use the funding from this round to expand its partnerships with health insurance companies and expand its product portfolio. Demand for digitalization solutions for the healthcare market is growing worldwide. Experts already estimate revenue in the European digital healthcare market at nearly €2.1 billion.
The networking of doctor and patient
Temedica was founded in Munich in 2016 under the name physiovia GmbH and has quickly established itself in the German healthcare market. The company offers digital solutions to improve patient care in the areas of therapy and prevention. The "physiovia" app connects doctors and patients: The patient receives a personalized home exercise plan that accompanies them during and beyond their therapy with therapy-supporting activities and medical background knowledge. At the same time, doctors and therapists can track the patient's individual recovery progress and adjust the therapy as needed.
With "pelvina," the startup also offers a digital healthcare program that contributes to the prevention of urinary incontinence in women. According to Temedica, more efficient therapies and sustainable prevention can result in significant long-term savings in healthcare costs.
"Digitalization has become an integral part of the healthcare market, and the need for corresponding solutions is growing day by day. That's why we see enormous potential for Temedica and its innovative products,"
says Herbert Henzler, one of the investors in the current financing round.
"The goal now is to position Temedica's products even more strongly in the market and to develop new products. As investors, we also want to provide Temedica with strategic support in this regard,"
complements lead investor Bernd Wendeln.
“Significant cost savings in the healthcare system”
"The healthcare industry is one of the most important economic sectors, and the demand for digital solutions is enormous. With our products, we improve patient engagement and thus the quality of care. At the same time, the use of our solutions can achieve significant cost savings in the healthcare system,"
explained Gloria Seibert, founder and managing director of Temedica GmbHDuring product development, the requirements of patients, service providers and payers are consistently taken into account in order to enable positioning in the complex healthcare market.
"We will use the newly raised capital primarily to expand our partnerships with health insurance companies. Our vision is to use our digital solutions to support every type of medical therapy in which the patient is actively and independently involved. With a strong and excellently networked investor consortium, we can approach the next steps of the company's development in a targeted manner,"
says Gloria Seibert.
